Adverum Biotechnologies, Inc. (59) | Human Resources (38)
Browse by Subcategory
Recent Contracts
-
Employment Agreement
(Filed With SEC on March 29, 2022)
-
Form of Change in Control
(Filed With SEC on March 29, 2022)
-
Form of Performance Stock Unit Award Grant Notice and Performance Stock Unit Award Agreement under the 2014 Equity Incentive Award Plan
(Filed With SEC on March 29, 2022)
-
Consulting Agreement between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021
(Filed With SEC on November 4, 2021)
-
Separation Agreement and General Release of Claims between Adverum Biotechnologies, Inc. and Angela Thedinga, dated October 1, 2021
(Filed With SEC on November 4, 2021)
-
Non-Employee Director Compensation Policy, effective May 5, 2021
(Filed With SEC on May 6, 2021)
-
Employment Agreement
(Filed With SEC on March 29, 2022)
-
Employment Agreement between Adverum Biotechnologies, Inc. and Rupert D'Souza, dated as of November 12, 2021
(Filed With SEC on March 29, 2022)
-
Employment Agreement between Adverum Biotechnologies, Inc. and Brigit Riley, dated as of May 21, 2021
(Filed With SEC on March 29, 2022)
-
Employment Offer Letter with Julie Clark, dated April 2, 2020
(Filed With SEC on August 5, 2021)
-
Consulting Agreement between Adverum Biotechnologies, Inc. and Leone Patterson, dated June 24, 2021
(Filed With SEC on August 5, 2021)
-
Change in Control and Severance Agreement with Chris DeRespino, dated February 1, 2021
(Filed With SEC on August 5, 2021)
-
Change in Control and Severance Agreement with Julie Clark, dated May 25, 2021
(Filed With SEC on August 5, 2021)
-
Employment Offer Letter with Chris DeRespino, dated February 1, 2021
(Filed With SEC on August 5, 2021)
-
Consulting Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated March 18, 2021
(Filed With SEC on May 6, 2021)
-
Non-Employee Director Compensation Policy, effective March 31, 2021
(Filed With SEC on May 6, 2021)
-
Consulting Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021
(Filed With SEC on May 6, 2021)
-
Separation Agreement between Adverum Biotechnologies, Inc. and Thomas Leung, dated February 2, 2021
(Filed With SEC on May 6, 2021)
-
Separation Agreement between Adverum Biotechnologies, Inc. and Aaron Osborne, dated April 7, 2021
(Filed With SEC on May 6, 2021)
-
Adverum Biotechnologies, Inc. Amended and Restated 2006 Equity Incentive Plan
(Filed With SEC on August 10, 2020)
-
Amended and Restated Non-Employee Director Compensation Policy, effective June 22, 2020
(Filed With SEC on August 10, 2020)
-
Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated
(Filed With SEC on August 10, 2020)
-
Amended and Restated Change in Control and Severance Agreement with Leone Patterson, dated
(Filed With SEC on August 10, 2020)
-
Change in Control and Severance Agreement Laurent Fischer, dated
(Filed With SEC on August 10, 2020)
-
Employment Offer Letter with Laurent Fischer, dated
(Filed With SEC on August 10, 2020)
-
Adverum Biotechnologies, Inc. Amended and Restated 2014 Equity Incentive Plan
(Filed With SEC on August 10, 2020)
-
Employment Agreement, dated
(Filed With SEC on May 28, 2020)
-
Non-Employee Director Compensation Policy, effective December 13, 2019
(Filed With SEC on March 12, 2020)
-
Employment Agreement, dated October 11, 2019, among Adverum Biotechnologies, Inc. and Peter Soparkar
(Filed With SEC on November 7, 2019)
-
Employment Agreement, dated February 28, 2019, among Adverum Biotechnologies, Inc. and Aaron Osborne
(Filed With SEC on November 7, 2019)
-
Non-Employee Director Compensation Policy, effective August 15, 2019
(Filed With SEC on November 7, 2019)
-
Separation Letter and Consulting Agreement, dated September 3, 2019 and September 6, 2019, respectively, between Adverum Biotechnologies, Inc. and Jennifer Cheng
(Filed With SEC on November 7, 2019)
-
Separation and Consulting Agreement, dated July 31, 2019, between Adverum Biotechnologies, Inc. and Mehdi Gasmi
(Filed With SEC on November 7, 2019)
-
Separation Letter, dated May 1, 2019, between Adverum Biotechnologies, Inc. and Paul Cleveland
(Filed With SEC on August 8, 2019)
-
Employment Agreement, dated February 27, 2019, with Thomas Leung
(Filed With SEC on May 8, 2019)
-
Change in Control and Severance Agreement with Leone Patterson, dated October 24, 2018
(Filed With SEC on March 6, 2019)
-
Adverum Biotechnologies, Inc. 2014 Equity Incentive Award Plan, as amended and restated
(Filed With SEC on March 6, 2019)
-
Amendment to the Change in Control and Severance Agreement for Mehdi Gasmi
(Filed With SEC on March 6, 2019)